Key points are not available for this paper at this time.
•The presence and pathophysiological correlations of HF increase risk for cancer.•HF-GRMT does not have a clear effect on incident cancer.•Preclinical cardio-oncology models reveal a complex and multifactorial relationship.•Clinical research can identify circulating factors as biomarkers/therapeutic targets.
Boer et al. (Fri,) studied this question.